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Xanthogranulomatous cystitis (XC) is a rare benign chronic inﬂammatory disease of unknown etiology.
Curative treatment of XC requires surgical resection, and most of reported cases were treated by partial
cystectomy. Here we describe a case with XC that was treated using transurethral resection.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Xanthogranulomatous changes, histologically characterized by
the presence of lipid-laden macrophages, multinucleated giant
cells, and cholesterol clefts, have been reported in many sites,1 and
the kidney is the most common site in the urinary tract. Xanthog-
ranulomatous cystitis (XC) is a rare benign chronic inﬂammatory
disease of unknown etiology. In this report, we describe a case with
XC that was treated using transurethral resection.Case presentation
A 64-year-old female presented with repeated cystitis. At pre-
sentation, she had no lower urinary tract symptoms or hematuria.
She had a history of a pyelolithotomy for a right renal stone and a
partial ureterectomy with an ureterovesiconeostomy for a right
megaureter at the age of 30. Furthermore, she had a hysterectomy
at the age of 50 and a laparoscopic cholecystectomy in the previous
year. Physical examination was unremarkable, and laboratory data
revealed a normal hematological and biochemical proﬁle. Urinaly-
sis revealed 0e5 red blood cells and 0e1 white blood cell per high
power ﬁeld. Urine culture grew coagulase-negative Staphylococcus,
a-hemolytic Streptococcus, and Corynebacterium species. Urinary
cytology showed no malignant cells. Ultrasonography revealed
mild hydronephrosis in the right kidney, bilateral multiple renalþ81 3 3862 9140.
oto).
Inc. This is an open access article ucysts, and thickening of posterior bladder wall with no blood ﬂow
(Fig. 1). Her voiding function was normal with negligible post-void
residual urine. Cystoscopy revealed a papillary mucosa at the pos-
terior wall (Fig. 2). Enhanced computed tomography demonstrated
no stone or tumor in the right ureter and no appreciable change in
the bladder. Magnetic resonance imaging revealed no urachal
remnants. Cystoradiogram did not show vesicoureteral reﬂux.
Because the presence of bladder neoplasm could not be ruled
out, an endoscopic resection was performed. Histological exami-
nation revealed a yellow-brown specimen, including many foamy
macrophages that stained positive for CD68 (Fig. 3), inﬁltrated
neutrophils, and ﬁbrosis in the submucosal layer. These histological
ﬁndings led to the diagnosis of XC. There was no evidence of ma-
lignancy. The postoperative course was uneventful. The patient had
no recurrence 10 months after the surgery.
Discussion
XC is a rare inﬂammatory disease that is microscopically
characterized by multinucleated giant cells, lipid-laden macro-
phages (xanthoma cells), and cholesterol crystals, and macro-
scopically by soft yellow-brown plaques.1 Since the ﬁrst report by
Wassiljew in 1932,2 27 cases of XC have been reported in the
literature. All 28 cases, including the present report, had the
following clinical characteristics1e5 (Table 1): a median age of
46 years (range, 16e76 years) and no sexual predominance (14
cases in males, 13 cases in females, and one unknown).
The pathogenesis of XC is unclear. In the previously reported
cases, the proposed etiology includes an urachal remnant, a chronic
infection, foreign materials such as retained suture materials, ander the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Ultrasonic image of a sagittal view of the bladder showing thickening of the
bladder wall with no blood ﬂow.
Figure 2. Cystoscopy showing edematous papillary mucosa at the posterior wall.
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metabolism, and urethral stenosis.1,3e5 In the kidney, xanthogra-
nulomatous inﬂammation always develops as a consequence of an
infection, which is often associated with urinary obstruction. In the
present case, the XC may have been caused by repeated cystitis or
retained suture materials.
The location of XC was at the dome of the bladder in 18 of 28
cases, and 14 of the 28 cases were associated with an urachal lesion
(Table 1). In the present case, the posterior wall of the bladder was
involved, which indicates that there was no relationship with an
urachus.
XC has no speciﬁc clinical manifestations; therefore, it is difﬁcult
to distinguish from other bladder diseases, such as carcinoma. TheFigure 3. Microscopic examination of the lesion showing the presence of many foamy macr
shown in the right panel (400).main symptoms were lower abdominal palpable mass, cystitis-like
symptoms, discharge from the umbilicus, and painless macro-
hematuria. Therefore, the diagnosis of XC is usually based on
pathological examinations.
Curative treatment of XC requires surgical resection,3 and no
postoperative recurrence has been reported. Of the 28 published
cases, the treatment measure was partial resection in 22 cases,
transurethral resection in four cases including the present case,ophages that stained positive for CD68 (left, 100). Hematoxylin and eosin staining is
Table 1
Characteristics of the reported XC cases
Age Mean 46 (16e76)
Sex
Male 14
Female 13
Unknown 1
Site
Dome 18
Posterior wall 3
Lateral wall 2
Vesico-ureteric junction 1
Associated pathology
Urachal remnant 11
Urachal adenoma 2
Urachal adenocarcinoma 1
Ulcerative colitis 2
Urotherial carcinoma 1
Symptom
Abdominal mass 9
Frequency 9
Dysuria 7
Lower abdominal pain 7
Hematuria 6
Umbilical pus 3
Urgency 3
Treatment
Partial cystectomy 22
Total cystectomy 1
Augmentation cystoplasty 1
Transurethral resection 4
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small capacity bladder after the exclusion of neoplasm in one case.
The use of transurethral resection to treat XC was reported only inrecent years,5 possibly because of early detection via imaging tests.
Transurethral resection appears to be a minimally invasive and
curative treatment for small XC lesions.
Conclusion
XC is a rare benign chronic inﬂammatory disease. Curative
treatment of XC requires surgical resection, and a partial
cystectomy has been applied in most cases. The present case
suggests that a transurethral resection is a minimally invasive and
curative treatment for small XC lesions.
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